Clinical trials
Enrolling by invitation Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Affiliated Hospital of Zhejiang University | 2 |
| Guangdong Second Provincial General Hospital | 2 |
| Michael Pulsipher | 2 |
| Anhui Medical University | 1 |
| Asan Medical Center | 1 |
| AvenCell Therapeutics, Inc. | 1 |
| CareDx | 1 |
| Caribou Biosciences, Inc. | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Janssen Research & Development, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 19 |
| Myelodysplastic Syndromes | 6 |
| Lymphoma, Non-Hodgkin | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Hematologic Neoplasms | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, B-Cell | 2 |
| Neoplasm, Residual | 2 |
| Recurrence | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.